Integra LifeSciences Reports Third Quarter 2015 Financial Results

Go back to Integra LifeSciences Reports Third Quarter 2015 Financial Results

Integra LifeSciences (IART) Tops Q3 EPS by 1c, Updates FY Guidance

November 3, 2015 8:03 AM EST

Integra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.75, $0.01 better than the analyst estimate of $0.74. Revenue for the quarter came in at $226.4 million versus the consensus estimate of $224.08 million.

Integra LifeSciences sees FY2015 EPS of $3.05-$3.10, versus the consensus of $3.06. Integra LifeSciences sees FY2015... More